Connection
Ronda Henry-Tillman to Angiogenesis Inhibitors
This is a "connection" page, showing publications Ronda Henry-Tillman has written about Angiogenesis Inhibitors.
|
|
Connection Strength |
|
 |
|
 |
|
0.027 |
|
|
|
-
Makhoul I, Klimberg VS, Korourian S, Henry-Tillman RS, Siegel ER, Westbrook KC, Hutchins LF. Combined neoadjuvant chemotherapy with bevacizumab improves pathologic complete response in patients with hormone receptor negative operable or locally advanced breast cancer. Am J Clin Oncol. 2015 Feb; 38(1):74-9.
Score: 0.027